Vorapaxar-d5
Vorapaxar-d5 is deuterated labeled Vorapaxar. Vorapaxar (SCH 530348), an antiplatelet agent, is a selective, orally active, and competitive thrombin receptor protease-activated receptor (PAR-1) antagonist (Ki=8.1 nM). Vorapaxar (SCH 530348) inhibits thrombin receptor-activating peptide (TRAP) -induced platelet aggregation in a dose-dependent manner[1].
Product Specifications
Product Name Alternative
SCH 530348-d5
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Protease Activated Receptor (PAR)
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Solubility
10 mM in DMSO
Smiles
FC1=C(C=CC=C1)C(C=N2)=CC=C2/C=C/[C@@H](C(C(C3)C4)CC[C@H]3NC(OC([2H])(C([2H])([2H])[2H])[2H])=O)C5C4C(O[C@@H]5C)=O
Molecular Formula
C29H28D5FN2O4
Molecular Weight
497.61
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD63 (MX-49.129.5), CF647 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF488A conjugate, 0.1mg/mL
Filaggrin (Keratinocyte Differentiation Marker) (FLG/1561), CF640R conjugate, 0.1mg/mL
Glucose Regulated Protein 94 (GRP94) (HSP90B1/1192), CF405S conjugate, 0.1mg/mL
Major Vault Protein (MVP) (1014), CF488A conjugate, 0.1mg/mL
